NCT04038619 2026-03-18
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Recruiting
Clinical Trials
6 trialsNCT07264985 2025-12-04
Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib
Hubei Cancer Hospital
Not yet recruiting
NCT06892093 2025-09-08
Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase NA Recruiting
NCT06152471 2023-11-30
ASF-BC
Uppsala University Hospital
Phase 3 Unknown
NCT04736186 2021-02-03
Prevention and Treatment of Pyrrolitinib-associated Diarrhea
Tianjin Medical University Cancer Institute and Hospital
Phase 2/3 Unknown
NCT02294786 2019-07-15
Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer
Novartis
Phase 2 Terminated